Related MeSH Hierarchy (4)
Diseases [C] » Infections [C01] » Bacterial Infections and Mycoses » Mycoses » Dermatomycoses » Tinea » Onychomycosis
Diseases [C] » Infections [C01] » Skin Diseases, Infectious » Dermatomycoses » Tinea » Onychomycosis
Diseases [C] » Skin and Connective Tissue Diseases [C17] » Skin Diseases » Nail Diseases » Onychomycosis
Diseases [C] » Skin and Connective Tissue Diseases [C17] » Skin Diseases » Skin Diseases, Infectious » Dermatomycoses » Tinea » Onychomycosis
Description
A fungal infection of the nail, usually caused by DERMATOPHYTES; YEASTS; or nondermatophyte MOLDS. MeSH
Hierarchy View
Approved Indicated Drugs (6)
Phase 4 Indicated Drugs (4)
Phase 3 Indicated Drugs (2)
Phase 2 Indicated Drugs (19)
Phase 1 Indicated Drugs (4)
Other Experimental Indicated Drugs (2)
Organization Involved with Phase 4 Indications (14)
Organization Involved with Phase 3 Indications (13)
Organization Involved with Phase 2 Indications (42)
Centre de Recherche Dermatologique du Quebec Metropolitaine
Dermatology Research Center, Inc
Hisamitsu Pharmaceutical Co., Inc.
International Dermatology Research Inc.
Organization Involved with Phase 1 Indications (2)
Organization Involved with Other Experimental Indications (10)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
